NLRP3 and endothelial dysfunction: As previously described, these effects are largely mediated by the activation of the NLRP3 inflammasome and the inhibition of the SIRT3-SOD2 pathway, leading to increased mitochondrial ROS production and endothelial dysfunction [39].